| Identification | Back Directory | [Name]
Ebalzotan | [CAS]
149494-37-1 | [Synonyms]
Ebalzotan
2H-1-Benzopyran-5-carboxamide, 3,4-dihydro-N-(1-methylethyl)-3-[(1-methylethyl)propylamino]-, (3R)- | [Molecular Formula]
C19H30N2O2 | [MOL File]
149494-37-1.mol | [Molecular Weight]
318.45 |
| Hazard Information | Back Directory | [Uses]
Ebalzotan is a 5-HT1A receptor agonist with activity in the study of depression. Ebalzotan can serve as a precursor to important active pharmaceutical ingredients. The synthesis of Ebalzotan involves a multi-enzyme catalyzed reduction reaction to obtain saturated primary or secondary alcohols in high yields and high enantioselectivity[1]. | [References]
[1] Synthesis of robalzotan, ebalzotan, and rotigotine precursors via the stereoselective multienzymatic cascade reduction of α,β-unsaturated aldehydes DOI:10.1021/jo4003097 |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|